Literature DB >> 30153376

Absence of hexose-6-phosphate dehydrogenase results in reduced overall glucose consumption but does not prevent 11β-hydroxysteroid dehydrogenase-1-dependent glucocorticoid activation.

Philippe Marbet1, Petra Klusonova1, Julia Birk1, Denise V Kratschmar1, Alex Odermatt1.   

Abstract

Hexose-6-phosphate dehydrogenase (H6PD) is thought to be the major source of NADPH within the endoplasmic reticulum (ER), determining 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) reaction direction to convert inert 11-oxo- to potent 11β-hydroxyglucocorticoids. Here, we tested the hypothesis whether H6pd knock-out (KO) in primary murine bone marrow-derived macrophages results in a switch from 11β-HSD1 oxoreduction to dehydrogenation, thereby inactivating glucocorticoids (GC) and affecting macrophage phenotypic activation as well as causing a more aggressive M1 macrophage phenotype. H6pdKO did not lead to major disturbances of macrophage activation state, although a slightly more pronounced M1 phenotype was observed with enhanced proinflammatory cytokine release, an effect explained by the decreased 11β-HSD1-dependent GC activation. Unexpectedly, ablation of H6pd did not switch 11β-HSD1 reaction direction. A moderately decreased 11β-HSD1 oxoreduction activity by 40-50% was observed in H6pdKO M1 macrophages but dehydrogenation activity was undetectable, providing strong evidence for the existence of an alternative source of NADPH in the ER. H6pdKO M1 activated macrophages showed decreased phagocytic activity, most likely a result of the reduced 11β-HSD1-dependent GC activation. Other general macrophage functions reported to be influenced by GC, such as nitrite production and cholesterol efflux, were altered negligibly or not at all. Importantly, assessment of energy metabolism using an extracellular flux analyzer and lactate measurements revealed reduced overall glucose consumption in H6pdKO M1 activated macrophages, an effect that was GC independent. The GC-independent influence of H6PD on energy metabolism and the characterization of the alternative source of NADPH in the ER warrant further investigations. ENZYMES: 11β-HSD1, EC 1.1.1.146; H6PD, EC 1.1.1.47.
© 2018 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  11β-hydroxysteroid dehydrogenase; glucocorticoid; hexose-6-phosphate dehydrogenase; inflammation; macrophage

Mesh:

Substances:

Year:  2018        PMID: 30153376     DOI: 10.1111/febs.14642

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  2 in total

1.  Altered expression of the IGF2‑H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma.

Authors:  Patrick Scicluna; Stefano Caramuta; Hanna Kjellin; Cheng Xu; Robin Fröbom; Monira Akhtar; Jiwei Gao; Hao Shi; Magnus Kjellman; Malin Almgren; Anders Höög; Jan Zedenius; Tomas J Ekström; Robert Bränström; Weng-Onn Lui; Catharina Larsson
Journal:  Int J Oncol       Date:  2022-09-28       Impact factor: 5.884

2.  18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress.

Authors:  Alberto Miceli; Vanessa Cossu; Cecilia Marini; Patrizia Castellani; Stefano Raffa; Maria Isabella Donegani; Silvia Bruno; Silvia Ravera; Laura Emionite; Anna Maria Orengo; Federica Grillo; Flavio Nobili; Silvia Morbelli; Antonio Uccelli; Gianmario Sambuceti; Matteo Bauckneht
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.